ArticlePharmaceutics2019

Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.

Erin Tay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.